Clinical Trials Browser

Completed × brexucabtagene autoleucel × 90 days × Clear all

NCT02625480 2026-04-09

ZUMA-4

Phase 1/2 Completed

Recurrence, Lymphoma, B-Cell

NCT02601313 2026-03-18

ZUMA-2

Phase 2 Completed

105 enrolled 33 charts 3 FDA

Lymphoma, Mantle-Cell